NeueHealth, Inc. (NYSE:NEUE) CEO Sells $191,685.40 in Stock

NeueHealth, Inc. (NYSE:NEUE) CEO George Lawrence Mikan III sold 26,660 shares of the firm’s stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $7.19, for a total transaction of $191,685.40. Following the sale, the chief executive officer now owns 178,756 shares of the company’s stock, valued at $1,285,255.64. This trade represents a 12.98 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

George Lawrence Mikan III also recently made the following trade(s):

• On Wednesday, March 12th, George Lawrence Mikan III sold 13,180 shares of NeueHealth stock. The stock was sold at an average price of $6.93, for a total value of $91,337.40.
• On Monday, March 10th, George Lawrence Mikan III sold 1,604 shares of NeueHealth stock. The shares were sold at an average price of $7.06, for a total transaction of $11,324.24.
• On Monday, January 6th, George Lawrence Mikan III sold 31,798 shares of NeueHealth stock. The shares were sold at an average price of $7.33, for a total transaction of $233,079.34.
• On Tuesday, December 17th, George Lawrence Mikan III sold 16,803 shares of NeueHealth stock. The shares were sold at an average price of $4.18, for a total value of $70,236.54.

NeueHealth Stock Up 0.2 %

NEUE opened at $6.75 on Friday. The stock has a market capitalization of $55.96 million, a price-to-earnings ratio of -0.13 and a beta of 0.56. NeueHealth, Inc. has a twelve month low of $3.79 and a twelve month high of $7.66. The company has a 50-day simple moving average of $7.30 and a 200 day simple moving average of $6.00.

Analyst Ratings Changes

Separately, Royal Bank of Canada dropped their price objective on NeueHealth from $8.00 to $7.00 and set a “sector perform” rating for the company in a report on Monday, December 9th.

Institutional Investors Weigh In On NeueHealth

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Partners Group Holding AG bought a new position in NeueHealth in the third quarter valued at about $463,000. Northern Trust Corp lifted its holdings in shares of NeueHealth by 66.8% in the fourth quarter. Northern Trust Corp now owns 32,644 shares of the company’s stock worth $242,000 after acquiring an additional 13,074 shares during the last quarter. Finally, Virtu Financial LLC acquired a new stake in shares of NeueHealth in the 4th quarter valued at approximately $76,000. 63.88% of the stock is currently owned by institutional investors.

NeueHealth Company Profile

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.